TrademarkOpen
Search / United States / 79376918

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark / Service Mark

SEQUANTRIX

Registered
Used for: Biotechnological pharmaceutical preparations for medical use for the treatment of fibrosis; pharmaceutical preparations…
Show more

Class 5: Biotechnological pharmaceutical preparations for medical use for the treatment of fibrosis; pharmaceutical preparations for the treatment of fibrosis; pharmaceutical preparations for treating fibrosis
Class 42: Medical research; biomedical research and development services; biochemistry research and development services; biotechnological research and development services; pharmaceutical research and development services

Class 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS

Status timeline

  1. 24 Aug 2023
    Application received from the International Bureau (Madrid)
    Sn Assigned For Sect 66a Appl From Ib
  2. 25 Mar 2024
    Assigned to an examining attorney
    Assigned To Examiner
  3. 27 Mar 2024
    Office action issued
    Non-Final Action Written
  4. 10 Jun 2024
    Response to office action filed
    Teas Response To Office Action Received
  5. 11 Jun 2024
    Approved for publication
    Approved For Pub - Principal Register
  6. 16 Jul 2024
    Published for opposition
    Published For Opposition
  7. 1 Oct 2024
    Registered on the Principal Register
    Registered-Principal Register
All 28 events
2025-11-13New Representative At Ib Received
2025-03-29Final Decision Transaction Processed By Ib
2025-03-10Final Disposition Processed
2025-03-10Final Disposition Notice Sent To Ib
2025-02-08Notification Of Possible Opposition - Processed By Ib
2025-01-22Notification Of Possible Opposition Created, To Be Sent To Ib
2025-01-22Notification Of Possible Opposition Sent To Ib
2025-01-01Final Disposition Notice Created, To Be Sent To Ib
2024-10-01Registered-Principal Register
2024-10-01Notice Of Registration Confirmation Emailed
2024-07-16Published For Opposition
2024-07-16Official Gazette Publication Confirmation E-Mailed
2024-07-16Published For Opposition
2024-07-16Official Gazette Publication Confirmation E-Mailed
2024-06-26Notification Of Notice Of Publication E-Mailed
2024-06-11Teas/Email Correspondence Entered
2024-06-11Approved For Pub - Principal Register
2024-06-10Teas Response To Office Action Received
2024-06-10Correspondence Received In Law Office
2024-05-08Refusal Processed By Ib
2024-04-15Request For Reinstatement Received
2024-04-15Non-Final Action Mailed - Refusal Sent To Ib
2024-03-28Non-Final Action (Ib Refusal) Prepared For Review
2024-03-27Non-Final Action Written
2024-03-25Assigned To Examiner
2023-08-29Application Filing Receipt Mailed
2023-08-25New Application Office Supplied Data Entered
2023-08-24Sn Assigned For Sect 66a Appl From Ib

Goods & services by class

Class 5 Pharmaceuticals & supplements

Biotechnological pharmaceutical preparations for medical use for the treatment of fibrosis; pharmaceutical preparations for the treatment of fibrosis; pharmaceutical preparations for treating fibrosis

Class 42 Technology & SaaS

Medical research; biomedical research and development services; biochemistry research and development services; biotechnological research and development services; pharmaceutical research and development services

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 3 Apr 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.